EXCLUSIVE ONLINE CONTENT
Flexion Therapeutics, Inc. recently announced clearance of the company’s Investigational New Drug (IND) application for FX201 in knee osteoarthritis.
This new global nanotechnology association will bolster the necessary links between research and industries and facilitate the adoption and commercialization of…….
Crown Bioscience recently announced the launch of a new tumor organoid drug development platform with the potential to significantly improve the……
Pfenex Inc. recently announced the US FDA has approved the new drug application (NDA) for PF708 submitted under the 505(b)(2) regulatory pathway, with…
Cabaletta Bio, Inc. recently announced it has received clearance of its IND application from the US FDA to initiate a first-in-human clinical trial of…..